Select Bibliography

Filter by any of these (after searching):

Bartlett, N L

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 2 items

Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.

Bartlett, N L , Niedzwiecki, D , Johnson, J L , Friedberg, J W ... - - Ann. Oncol. - 2007

Manuscript - Primary - Primary - Lymphoma - CALGB-59804

A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)

Martin, P , Jung, S -H , Pitcher, B , Bartlett, N L , Blum, K A ... - - Ann. Oncol - 2017

Manuscript - Primary - Primary - Lymphoma - CALGB-50803